View in EDS

Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.

Saved in:
Bibliographic Details
Title: Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
Authors: Sternschuss M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Toumbacaris N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA., Das JP; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA., Powles T; Barts Cancer Institute Biomedical Research Center, Queen Mary University of London, London, UK., Kotecha RR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Laccetti AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Xiao H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Feld E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., McHugh DJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Keegan NM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Bajorin DF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Shah NJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Iyer G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Aggen DH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Teo MY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Ostrovnaya I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA., Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: rosenbj1@mskcc.org.
Source: ESMO open [ESMO Open] 2025 Jun; Vol. 10 (6), pp. 105305. Date of Electronic Publication: 2025 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40479863
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sternschuss+M%22">Sternschuss M</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Toumbacaris+N%22">Toumbacaris N</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Das+JP%22">Das JP</searchLink>; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Powles+T%22">Powles T</searchLink>; Barts Cancer Institute Biomedical Research Center, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kotecha+RR%22">Kotecha RR</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Laccetti+AL%22">Laccetti AL</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+H%22">Xiao H</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Feld+E%22">Feld E</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22McHugh+DJ%22">McHugh DJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Keegan+NM%22">Keegan NM</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Bajorin+DF%22">Bajorin DF</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Funt+SA%22">Funt SA</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Shah+NJ%22">Shah NJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+G%22">Iyer G</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Aggen+DH%22">Aggen DH</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Teo+MY%22">Teo MY</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ostrovnaya+I%22">Ostrovnaya I</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+JE%22">Rosenberg JE</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: rosenbj1@mskcc.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2025 Jun; Vol. 10 (6), pp. 105305. <i>Date of Electronic Publication: </i>2025 Jun 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40479863
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmoop.2025.105305
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 105305
    Titles:
      – TitleFull: Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sternschuss M
      – PersonEntity:
          Name:
            NameFull: Toumbacaris N
      – PersonEntity:
          Name:
            NameFull: Das JP
      – PersonEntity:
          Name:
            NameFull: Powles T
      – PersonEntity:
          Name:
            NameFull: Kotecha RR
      – PersonEntity:
          Name:
            NameFull: Laccetti AL
      – PersonEntity:
          Name:
            NameFull: Xiao H
      – PersonEntity:
          Name:
            NameFull: Feld E
      – PersonEntity:
          Name:
            NameFull: McHugh DJ
      – PersonEntity:
          Name:
            NameFull: Keegan NM
      – PersonEntity:
          Name:
            NameFull: Bajorin DF
      – PersonEntity:
          Name:
            NameFull: Funt SA
      – PersonEntity:
          Name:
            NameFull: Shah NJ
      – PersonEntity:
          Name:
            NameFull: Iyer G
      – PersonEntity:
          Name:
            NameFull: Aggen DH
      – PersonEntity:
          Name:
            NameFull: Teo MY
      – PersonEntity:
          Name:
            NameFull: Ostrovnaya I
      – PersonEntity:
          Name:
            NameFull: Rosenberg JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-7029
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ESMO open
              Type: main
ResultId 1